Bundled "Longevity Panels" / Executive Health Packages
Pre-packaged bundles combining dozens of the tests above, typically mixing genuinely Strong ones — CBC, lipids, HbA1c — with Weak or Emerging ones such as an epigenetic clock, full-body MRI or microbiome test, under a single premium price that can run to S$3,000–15,000+. Bundling does not average out the evidence quality of its components: a package is only as trustworthy as its weakest constituent test. The framing works against the evidence too, since “comprehensive” and “leave no stone unturned” describe precisely the strategy that, in a low-pretest-probability population, increases false positives, incidental findings, downstream anxiety and unnecessary follow-up procedures without a proven mortality or morbidity benefit.
No published trial evidence shows that any specific “longevity panel” bundle, as a package, improves mortality or morbidity outcomes compared with guideline-based, risk-stratified testing. A Cochrane systematic review of general health checks in adults (Krogsbøll et al., PMID 30699470, 15 RCTs, more than 250,000 participants) found no reduction in all-cause, cardiovascular or cancer mortality from inviting asymptomatic adults to general health checks. The individual components should be evaluated — and paid for — on their own evidence, not on the appeal of the bundle.
Singapore pricing. We have a full price breakdown for this test, using checked 2026 figures from named providers — read the price guide →